Evaluation of partial area under the concentration time curve to estimate midazolam apparent oral clearance for cytochrome P450 3A phenotyping

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Drug Metabolism and Drug Interactions

• Publication date

  2013-12-01

• Fields of study

  Medicine, Mathematics

• Identifiers
  DOI 10.1515/dmdi-2013-0040PMID 24114901
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of limited sampling models for prediction of oral midazolam AUC for CYP3A phenotyping and drug interaction studies

  2012cited by this paper
• Truncated areas under the curve in the assessment of pioglitazone bioequivalenceData from a single-center, single-dose, randomized, open-label, 2-way cross-over bioequivalence study of two formulations of pioglitazone 45 mg tablets under fasting conditions

  2011cited by this paper
• Evaluation of a morphine maturation model for the prediction of morphine clearance in children: how accurate is the predictive performance of the model?

  2011cited by this paper
• Determining the Time Course of CYP3A Inhibition by Potent Reversible and Irreversible CYP3A Inhibitors Using A Limited Sampling Strategy

  2011cited by this paper
• Vitamin D insufficiency and incident chronic kidney disease in Australia: the AUSDIAB study

  2011cited by this paper
• Assessment of oral midazolam limited sampling strategies to predict area under the concentration time curve (AUC) during cytochrome P450 (CYP) 3A baseline, inhibition and induction or activation.

  2010cited by this paper
• Proposal of a new limited sampling strategy to predict CYP3A activity using a partial AUC of midazolam

  2010influential reference
• Bioequivalence study of two different tablet formulations of donepezil using truncated areas under the curve

  2010cited by this paper
• Limited Sampling Strategies for Predicting Area Under the Concentration-Time Curve of Mycophenolic Acid in Islet Transplant Recipients

  2010cited by this paper
• Effect of Different Durations of Ketoconazole Dosing on the Single‐Dose Pharmacokinetics of Midazolam: Shortening the Paradigm

  2009cited by this paper
• Limitations of Using a Single Postdose Midazolam Concentration to Predict CYP3A‐Mediated Drug Interactions

  2008cited by this paper
• Human intestinal P‐glycoprotein activity estimated by the model substrate digoxin

  2007cited by this paper
• Ketoconazole Renders Poor CYP3A Phenotype Status With Midazolam as Probe Drug

  2006cited by this paper
• Limited Sampling Models for Oral Midazolam: Midazolam Plasma Concentrations, Not the Ratio of 1‐Hydroxymidazolam to Midazolam Plasma Concentrations, Accurately Predicts AUC as a Biomarker of CYP3A Activity

  2006cited by this paper
• DURATION OF PLECONARIL EFFECT ON CYTOCHROME P450 3A ACTIVITY IN HEALTHY ADULTS USING THE ORAL BIOMARKER MIDAZOLAM

  2006cited by this paper
• Beyond Cyclosporine: A Systematic Review of Limited Sampling Strategies for Other Immunosuppressants

  2006cited by this paper
• Comparison of midazolam and simvastatin as cytochrome P450 3A probes

  2006influential reference
• Single‐point sampling for assessment of constitutive, induced, and inhibited cytochrome P450 3A activity with alfentanil or midazolam

  2005cited by this paper
• Center specificity in the limited sampling model (LSM): can the LSM developed from healthy subjects be extended to disease states?

  2003cited by this paper
• Pleconaril, a Novel Antipicornaviral Agent

  2003cited by this paper
• Exposure‐Dependent Inhibition of Intestinal and Hepatic CYP3A4 In Vivo by Grapefruit Juice

  2003cited by this paper
• The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity

  2003cited by this paper
• The Conduct of In Vitro and In Vivo Drug‐Drug Interaction Studies: A PhRMA Perspective

  2003cited by this paper
• A Limited Sampling Method for the Estimation of Serum Calcitriol Area under the Curve in Cancer Patients

  2003cited by this paper
• Pharmacokinetics of midazolam and 1'-hydroxymidazolam in Chinese with different CYP3A5 genotypes.

  2002cited by this paper
• Limited Sampling Strategy to Predict AUC of the CYP3A Phenotyping Probe Midazolam in Adults: Application to Various Assay Techniques

  2002cited by this paper
• Single Plasma Concentrations of 1′‐Hydroxymidazolam or the Ratio of 1′‐Hydroxymidazolam: Midazolam Do Not Predict Midazolam Clearance in Healthy Subjects

  2002cited by this paper
• Equivalence approaches *

  2002cited by this paper
• Development and Validation of Limited-Sampling Strategies for Predicting Amoxicillin Pharmacokinetic and Pharmacodynamic Parameters

  2001cited by this paper
• Single plasma sampling to predict oral clearance of CYP3A probe midazolam.

  2001cited by this paper
• Limited Sampling Strategies for Estimating Cyclosporin Area Under the Concentration–Time Curve: Review of Current Algorithms

  2001cited by this paper
• In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration.

  2001cited by this paper
• CYP3A activity in African American and European American men: Population differences and functional effect of the CYP3A4*1B 5′‐promoter region polymorphism

  2000cited by this paper
• Limited Sampling Strategies

  2000cited by this paper
• Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes.

  2000cited by this paper
• Limited sampling strategy for mycophenolic acid area under the curve.

  2000cited by this paper
• A Limited Sampling Strategy for the Estimation of 12‐Hour SangCya and Neoral AUCs in Renal Transplant Recipients

  1999cited by this paper
• Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: Effect of ketoconazole

  1999cited by this paper
• Limited-sampling strategy models for estimating the area under the plasma concentration–time curve for amlodipine

  1999cited by this paper
• Development of a Limited Sampling Approach in Pharmacokinetic Studies: Experience with the Antiepilepsy Drug Tiagabine

  1998cited by this paper
• Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapy. Technical note.

  1998cited by this paper
• Effects of cytokines on antiviral pharmacokinetics: an alternative approach to assessment of drug interactions using bioequivalence guidelines

  1996cited by this paper
• Oral first‐pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A‐mediated metabolism

  1996cited by this paper
• Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals.

  1995cited by this paper
• Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapy.

  1991cited by this paper
• Some suggestions for measuring predictive performance

  1981cited by this paper

• Limited Sampling Strategy of Rosuvastatin Single-Time-point Concentrations Accurately Estimate Exposure and Constitutive Transporter Activities in Healthy Adults.

  2025cites this paper
• Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Substrate

  2019cites this paper
• Midazolam Limited Sampling Strategy With a Population Pharmacokinetic Approach to Simultaneously Estimate Cytochrome P450 (CYP) 3A Constitutive, Inhibition, and Induction/Activation Conditions in Healthy Adults

  2019cites this paper
• A Systematic Review of Drug Metabolism Studies of Plants With Anticancer Properties: Approaches Applied and Limitations

  2019cites this paper
• Midazolam Single Time Point Concentrations to Estimate Exposure and Cytochrome P450 (CYP) 3A Constitutive Activity Utilizing Limited Sampling Strategy With a Population Pharmacokinetic Approach

  2018cites this paper
• Evaluation of Omeprazole Limited Sampling Strategies to Estimate Constitutive Cytochrome P450 2C19 Activity in Healthy Adults

  2018cites this paper
• CYP3A activity: towards dose adaptation to the individual

  2016cites this paper
• Limited Sampling Strategy of Partial Area Under the Concentration–Time Curves to Estimate Midazolam Systemic Clearance for Cytochrome P450 3A Phenotyping

  2015cites this paper